There is good news for diabetic patients. A cheaper form of Januvia (sitagliptin), which is considered effective in this disease, is about to come on the market.
The patent for sitagliptin expired this month. Many Indian pharmaceutical companies are now planning to launch it.
Now the price of Sitagliptin will drop significantly. It is expected to remain only one-third of the current prices.
With the introduction of generic versions of the diabetes drug, the cost of this disease will be reduced by one-third.
Let us tell you that earlier patients suffering from diabetes had to spend about 45 rupees daily on this medicine.
After the arrival of this new generic version, its cost will be only 8 to 18 rupees, which will be quite affordable.
US firm Merck's generic versions of Januvia are set to launch in the next few months as soon as the sitagliptin patent expires.
Dr. Reddy's, Glenmark, Sun Pharma, and JB Chemicals are going to hit the market next week with the generic version of this drug.
Dr. Reddy's, Glenmark, Sun Pharma, and JB Chemicals are going to hit the market next week with the generic version of this drug.